ML19327A263

From kanterella
Jump to navigation Jump to search
Responds to FOIA Request for NRC Insp Ltrs,Repts & Responses for Pharmatopes,Inc & Pharmaco Nuclear,Inc Facilities. Forwards App a Documents.Info Partially Withheld:Names & Identifying Info (Ref FOIA Exemption 6).W/o Encls
ML19327A263
Person / Time
Issue date: 07/29/1980
From: Felton J
NRC OFFICE OF ADMINISTRATION (ADM)
To: Mcdonald D
NUCLEAR PHARMACY, INC.
References
FOIA-80-354 NUDOCS 8008050087
Download: ML19327A263 (2)


Text

!

A N

[

%g UNITED STATES 5' M '

NUCLEAR REGULATORY COMMISSION o

3 E

WASHINGTON, D. C. 20555 S

    1. l i

July 29, 1980 Ms. Debra Mcdonald Nuclear Pharmacy, Inc.

P.O. Box 25141 IN RESPONSE REFER Albuquerque, NM 87125 TO F01A-80-354

Dear Ms. Mcdonald:

This is in response to your letter of July 7,1980, in which you requested, pursuant to the Freedom of Information Act, copies of NRC inspection letters or reports and response's thereto for Pharmatopes, Inc., and Pharmaco Nuclear, Inc., facilities as enumerated in your request.

Please find enclosed the documents, listed on Appendix A, which are subject to your request.

Portions of document 4 under License No.12-17910-01 MD have been deleted in order to withhold the name and other identifying information pertaining so an indivi' dual exposed to radiation.

Because disclosure of this information would constitute a clearly unwarranted invasion of personal privacy, it is being withheld from disclosure pursuant-to Exemption (6) of the Freedom of Information Act (5 U.S.C.

552(b)(6)) and 10 CFR 9.5(a)(6) of the Commission's regulations.

Pursuant to 10 CFR 9.9 of the Commission's regulations, it has been determined that the information withheld is exempt from production or disclosure, and that its production or disclosure is contrary to the public interest.

The persons responsible for this denial are the undersigned and Mr. Victor Stello, Director, Office of Inspection and Enforcement.

This denial may be appealed to the Commission's Executive Director for Operations within 30 days from the receipt of this letter.

As provided in 10 CFR 9.11, any such appeal must be in writing, addressed to the Executive Director for Operations, U.S. Nuclear Regulatory Commission, Washington, DC 20555, and should clearly state on the envelope and in the letter that it,is an " Appeal from an Initial F0IA Decision."

This completes NRC. action on your request.

Sinc r ly, J. M. Felton, Director f

Division of Rules and Records Office of Administration

Enclosures:

As stated

.80080500FT

RE: F01A-80-356 q.

APPENDIX A A. Pharmaco Nuclear, Inc.

License No. 34-16405-01MD & -02MD

1. Fonn AEC-591 dated 6/10/76
2. Form NRC-591 dated 8/16/79 License No. 12-17910-01' 1
1. Letter 5/7/80 A. B. Davis to Pharmaco Nuclear, Inc. (2 pages)
2. Inspection Report No. 30-13622/80-01 (12 pages)
3. Letter 11/21/79 A. B. Davis to Pharmaco Nuclear, Inc.

M. Letter 11/5/79 F. Comer to A. B. Davis (3 pages)

5. Letter 10/25/79 A. B. Davis to Pharmaco Nuclear, Inc. (2 pages)

License No. 37-18467-01MD

1. Letter 1/7/80 R. McClintock' to Pharmaco Nuclear, Inc.
2. Letter 12/24/79 G. Redmore to R. McClintock
3. Letter 12/13/79 R. McClintock to Pharmaco Nuclear, Inc. (3 pages)

License No. 24-16617-01MD

1. Letter 1/18/80 A. B. Davis to Pharmaco Nucl' ear, Inc.
2. Letter 1/7/80 R. Keesee to A. B.- Davis
3. Letter 1/2/80 A. B. Davis to Pharmaco Nuclear, Inc.(2 pages)
4. Letfer 8/15/78 A. B. Davis to Pharmaco Nuclear, Inc(2 pages)
5. Draft Inspection Report No. 0311339/78-01 (2 pages)
6. Letter 6/16/76 J. M. Allan to Pharmaco Nuclear, Inc.
7. Letter 6/4/76 R. Keesee to J. M. Allan
8. Letter 5/26/76 J. M. Allan to Pharmaco Nuclear, Inc.(3 pages)
8. Pharmatopes, Inc.

License No. 08-18308-01MD

1. Letter 12/10/)9 R. McClintock to Pharmatopes, Inc.
2. Letter 11/20/79 R. Irwin to R. McClintock
3. Letter 11/14/79 R. McClintock to Pharmatopes, Inc.
4. Letter 10/17/79 R. Irwin to R. McClintock (3 pages)
5. Letter 9/27/79 R. McClintock to Pharmatopes, Inc. (4 pages)
6. Letter 3/23/79 R. McClintock to Pharmatopes, Inc.
7. Letter 3/6/79 R. Irwin to R. McClintock (2 pages)
8. Letter 2/23/79 R. McClintock to Pharmatopes,,Inc..(3 pages)

License No. 45-17769-01MD_

1. Form AEC-591 dated 11/15/78 License No. 45-18378-01MD
1. Letter 2/6/80 J. P. Stohr to Pharmatopes, Inc.
2. Letter 1/28/80 M. Potter to R. Woodruff
3. Letter 1/18/80 J. P. Stohr to Pharmatopes, Inc. (3 pages)
  • Indicates portions of document have been deleted.

E

RE: F0! A 354 '

2 License No. 21-17189-01 1.

Letter 4/11/78 W. Fisher to Pharmatopes, Inc. (2 pages) 2.

Letter 1/26/77 J. Cooper to Pharmatopes, Inc.

3.

Form AEC-591 for Inspection of 1/12/77 4.

Draft Inspection Report No. 7701 (17 pages)

D e

t e

i 1

km.m.